Discovery Labs (DSCO) +12.5% premarket after signing an agreement to manufacture and supply...

|By:, SA News Editor

Discovery Labs (DSCO) +12.5% premarket after signing an agreement to manufacture and supply product for the commercial introduction of Afectair, a device that assists patients requiring ventilator support with the delivery of aerosolized medications. Afectair was cleared last week by the FDA for U.S. commercial use.